CN1118265A

CN1118265A - Capsule for eliminating pathogenic factor and alleviating pain

Info

Publication number: CN1118265A
Application number: CN 94115964
Authority: CN
Inventors: 栗清华
Original assignee: Individual
Current assignee: Individual
Priority date: 1994-09-10
Filing date: 1994-09-10
Publication date: 1996-03-13
Anticipated expiration: 2014-09-10
Also published as: CN1060347C

Abstract

The antalgic capsule which can ease the pain of trige minal neuralgia in short term is prepared with 11 Chinese-medicinal materials such as Chinese angelica root, ox gallstone, asarum herb, Fructus piperis longi, schizonepeta, etc., and features high curative effect (effective rate of 90%), and basically no recurrence.

Description

Capsule for eliminating pathogenic factor and alleviating pain

The present invention relates to the prosopalgic Chinese patent medicine of a kind of treatment.

The prosopalgic measure of known treatment has operative therapy and Western medicine analgesic carbamazepine etc., but side effect is many and easily recurrence, does not have the radical cure effect.The traditional Chinese medical science is used the perverse and block therapy pain relieving of pin always, but general curative effect is of short duration, and is difficult as long-term or radical cure treatment means.

In traditional Chinese medical science works,, only in Chinese traditional treatment gout or prosopodynia, find similar description to the unspecial record of treatment trigeminal neuralgia.As putting down in writing in " Zhang Shi doctor logical " book: " prosopodynia ... can not the opening speech, hands touches i.e. pain, this is that positive yin channel network is subjected to pathogenic wind toxic, imports meridians into, blood clotting is stagnant and not all right." traditional Chinese medical science thinks that prosopodynia is many stagnant relevant with the rheumatism stasis of blood, so the rule of treatment is used dispelling wind and removing obstruction in the collateral more, methods such as heat clearing and blood stasis dispersing or liver-smoothing, qi-regulating.Though certain curative effect is arranged, specific aim is poor, and is still undesirable to treatment trigeminal neuralgia curative effect.

The purpose of this invention is to provide a kind of method and treat prosopalgic capsule for eliminating pathogenic factor and alleviating pain Chinese patent medicine with promoting blood circulation by removing wind, suppressing the hyperactive liver the kidney warming, blood-activating analgetic.

For achieving the above object, the main medicine of capsule for eliminating pathogenic factor and alleviating pain consists of Radix Angelicae Sinensis, Calculus Bovis, Herba Asari, Fructus Piperis Longi, Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, Rhizoma Cimicifugae etc.; Wherein Radix Angelicae Sinensis and Calculus Bovis, Herba Asari, Fructus Piperis Longi, the weight ratio of Pericarpium Zanthoxyli is 1～1.2: 0.60～0.75: 0.13～0.33: 0.8～1.0: 0.7～0.9; Fructus Piperis Longi and Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, the weight ratio of Rhizoma Cimicifugae is 1: 1, the above-mentioned Chinese medicine of respectively distinguishing the flavor of is cleaned dried, and screens out impurity, pulverization is with smalls Co ⁶⁰The illumination-based disinfection sterilization, in capsule of dress people's glue, every capsules includes Chinese medicine powder 0.4～0.5 gram, promptly gets the capsule for eliminating pathogenic factor and alleviating pain Chinese patent medicine.

The instructions of taking of this Chinese patent medicine is, looks trigeminal neuralgia patient course of disease length and physical condition, takes each oral 10～14 every day 2～3 times.Taking ten days is a course of treatment, and finish back drug withdrawal two days first course of treatment, continues to take a course of treatment.Can obtain recovery from illness general two courses of treatment, and indivedual persons take three courses of treatment at most and then can fully recover.

Reasonable recipe of the present invention, wherein, the Radix Angelicae Sinensis blood circulation promoting and blood stasis dispelling, Calculus Bovis heat clearing away poison, endogenous wind stopping relieves the pain; Herba Asari is ideal pain relieving good medicine, the Fructus Piperis Longi warming middle-JIAO to relieve pain; Pericarpium Zanthoxyli is controlled insufficiency of the spleen pain; Evil poison is dispersed in the feasible convulsion pain relieving of Radix Saposhnikoviae, Herba Schizonepetae, and Fructus Carpesii is a toil class medicine, and the blood stasis dispelling effect is arranged; The Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling, the Radix Scrophulariae nourishing YIN and supplementing the kidney, heat-clearing and toxic substances removing, Rhizoma Cimicifugae have the yang invigorating disperse function.Because of a little, to trigeminal neuralgia pain relieving spasmolytic targetedly, the eliminating evil effect of invigorating blood circulation, can alleviate prosopalgic symptom in a short time, have instant effect, simple and easy to do, advantages such as short treating period, more domestic at present tcm therapy is remarkably productive, has the treating both the principal and secondary aspects of a disease effect, clinical statistics 100 examples, effective percentage reaches 90%, and through observation in 1～3 year, efficacy consolidation, healing person does not have rebound phenomenon more substantially.

100 routine trigeminal neuralgia patient curative effect statistical tables

Curative effect case number disease time	Alleviate fully (people)	Alleviate (people)	Invalid (people)	Patient's number (people)
Curative effect case number disease time	Alleviate fully (people)	Alleviate (people)	Invalid (people)	Patient's number (people)	Below 1 year	????4	????2	????2	????8
2 years to 3 years	????22	????28	????2	????56	Below 1 year	????4	????2	????2	????8
2 years to 3 years	????22	????28	????2	????56	More than 3 years	????14	????20	????2	????36
Curative effect statistics (%)	????40	????50	????10	????00	More than 3 years	????14	????20	????2	????36

Among the 100 routine trigeminal neuralgia patients, male 46 people, women 54 people; 30～40 years old 12 age people, 40～50 years old 44 people, 50～60 years old 26 people, 18 people more than 60 years old, most patient age is 40～60 years old.Among the 100 routine patients, all make a definite diagnosis before going to a doctor at various big hospital inside and outside the province, and undesirable through various Chinese and western medicine medicine multi-treatment effects, still continue outbreak, wherein 8 routine patients once did the nerve block operation, and radical cure yet.Among the 100 routine patients, be and treat an above patient course of treatment, the person that after treating 1～2 time, no longer do not go to a doctor, curative effect can't the not routine people's scope of statistics of judgement person.Curative effect judging standard is: after alleviation was oral Chinese patent medicine of the present invention fully, pain stopped in two courses of treatment, observed recidivist over three months.Alleviation is to take medicine after two courses of treatment, and pain alleviates to some extent or prolong the interval of showing effect to some extent, but the general operate as normal of patient and give birth to the reviver.Invalid is that symptom does not have the changer substantially before and after taking medicine.

The present invention does not all find adverse side effect after the patient takes surplus in the of 20,000, safe and reliable.

Embodiments of the invention are; the consumption prescription of two courses of treatment is: Radix Angelicae Sinensis 15～18g, Calculus Bovis 8～10g, Herba Asari 2～5g, Fructus Piperis Longi 12～14g, Herba Schizonepetae 12～14g, Fructus Carpesii 12～14g, Pericarpium Zanthoxyli 10～12g, Radix Saposhnikoviae 12～14g, Rhizoma Chuanxiong 12～14g, Radix Scrophulariae 12～14g, Rhizoma Cimicifugae 12～14g.

Claims

1, the prosopalgic capsule for eliminating pathogenic factor and alleviating pain of a kind of treatment is characterized in that, main medicine consists of Radix Angelicae Sinensis, Calculus Bovis, Herba Asari, Fructus Piperis Longi, Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, Rhizoma Cimicifugae etc., wherein Radix Angelicae Sinensis and Calculus Bovis, Herba Asari, Fructus Piperis Longi, the weight ratio of Pericarpium Zanthoxyli are 1～1.2: 0.60～0.75: 0.13～0.33: 0.8～1.0: 0.7～0.9; Fructus Piperis Longi and Herba Schizonepetae, Fructus Carpesii, Pericarpium Zanthoxyli, Radix Saposhnikoviae, Rhizoma Chuanxiong, Radix Scrophulariae, the weight ratio of Rhizoma Cimicifugae is 1: 1, and aforementioned proportion Chinese medicine is ground into powder, is loaded in the capsule to get product.

2, capsule for eliminating pathogenic factor and alleviating pain according to claim 1; it is characterized in that; the consumption prescription of two courses of treatment is: Radix Angelicae Sinensis 15～18g; Calculus Bovis 8～10g, Herba Asari 2～5g, Fructus Piperis Longi 12～14B, Herba Schizonepetae 12～148, Fructus Carpesii 12～14g, Pericarpium Zanthoxyli 10～12g, Radix Saposhnikoviae 12～14g, Rhizoma Chuanxiong 12～14g, Radix Scrophulariae 12～14g, Rhizoma Cimicifugae 12～14g; aforementioned proportion Chinese medicine is ground into powder, made every capsule that contains 0.4～0.5 gram.